221 related articles for article (PubMed ID: 32347433)
1. Recent advances of the regulation roles of MicroRNA in glioblastoma.
Yan C; Kong X; Gong S; Liu F; Zhao Y
Int J Clin Oncol; 2020 Jul; 25(7):1215-1222. PubMed ID: 32347433
[TBL] [Abstract][Full Text] [Related]
2. Profiling of novel circulating microRNAs as a non-invasive biomarker in diagnosis and follow-up of high and low-grade gliomas.
Tabibkhooei A; Izadpanahi M; Arab A; Zare-Mirzaei A; Minaeian S; Rostami A; Mohsenian A
Clin Neurol Neurosurg; 2020 Mar; 190():105652. PubMed ID: 31896490
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs in glioblastoma pathogenesis and therapy: A comprehensive review.
Ahir BK; Ozer H; Engelhard HH; Lakka SS
Crit Rev Oncol Hematol; 2017 Dec; 120():22-33. PubMed ID: 29198335
[TBL] [Abstract][Full Text] [Related]
4. Short non-coding RNA sequencing of glioblastoma extracellular vesicles.
de Mooij T; Peterson TE; Evans J; McCutcheon B; Parney IF
J Neurooncol; 2020 Jan; 146(2):253-263. PubMed ID: 31912278
[TBL] [Abstract][Full Text] [Related]
5. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients.
Cheng W; Ren X; Cai J; Zhang C; Li M; Wang K; Liu Y; Han S; Wu A
Oncotarget; 2015 Oct; 6(30):29285-95. PubMed ID: 26320189
[TBL] [Abstract][Full Text] [Related]
6. MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma.
Costa PM; Cardoso AL; Custódia C; Cunha P; Pereira de Almeida L; Pedroso de Lima MC
J Control Release; 2015 Jun; 207():31-9. PubMed ID: 25861727
[TBL] [Abstract][Full Text] [Related]
7. Computational analysis and verification of molecular genetic targets for glioblastoma.
Xue L; Liu H; Chen Y; Wei L; Hong J
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32469390
[TBL] [Abstract][Full Text] [Related]
8. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
9. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX
PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080
[TBL] [Abstract][Full Text] [Related]
10. Risk Score based on microRNA expression signature is independent prognostic classifier of glioblastoma patients.
Sana J; Radova L; Lakomy R; Kren L; Fadrus P; Smrcka M; Besse A; Nekvindova J; Hermanova M; Jancalek R; Svoboda M; Hajduch M; Slampa P; Vyzula R; Slaby O
Carcinogenesis; 2014 Dec; 35(12):2756-62. PubMed ID: 25322872
[TBL] [Abstract][Full Text] [Related]
11. Global MicroRNA Expression Profiling Identifies Unique MicroRNA Pattern of Radioresistant Glioblastoma Cells.
Ondracek J; Fadrus P; Sana J; Besse A; Loja T; Vecera M; Radova L; Smrcka M; Slampa P; Slaby O
Anticancer Res; 2017 Mar; 37(3):1099-1104. PubMed ID: 28314270
[TBL] [Abstract][Full Text] [Related]
12. Role of micro-RNA (miRNA) in pathogenesis of glioblastoma.
Luo JW; Wang X; Yang Y; Mao Q
Eur Rev Med Pharmacol Sci; 2015; 19(9):1630-9. PubMed ID: 26004603
[TBL] [Abstract][Full Text] [Related]
13. A 4-miRNAs signature predicts survival in glioblastoma multiforme patients.
Yuan GQ; Wei NL; Mu LY; Wang XQ; Zhang YN; Zhou WN; Pan YW
Cancer Biomark; 2017 Dec; 20(4):443-452. PubMed ID: 28869437
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-1 suppresses glioblastoma in preclinical models by targeting fibronectin.
Yang CH; Wang Y; Sims M; Cai C; Pfeffer LM
Cancer Lett; 2019 Nov; 465():59-67. PubMed ID: 31491450
[TBL] [Abstract][Full Text] [Related]
15. miR-663 Suppresses Oncogenic Function of CXCR4 in Glioblastoma.
Shi Y; Chen C; Yu SZ; Liu Q; Rao J; Zhang HR; Xiao HL; Fu TW; Long H; He ZC; Zhou K; Yao XH; Cui YH; Zhang X; Ping YF; Bian XW
Clin Cancer Res; 2015 Sep; 21(17):4004-13. PubMed ID: 26023083
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs involved in the EGFR pathway in glioblastoma.
Xu B; Mei J; Ji W; Huo Z; Bian Z; Jiao J; Li X; Sun J; Shao J
Biomed Pharmacother; 2021 Feb; 134():111115. PubMed ID: 33341046
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics.
Shea A; Harish V; Afzal Z; Chijioke J; Kedir H; Dusmatova S; Roy A; Ramalinga M; Harris B; Blancato J; Verma M; Kumar D
Cancer Med; 2016 Aug; 5(8):1917-46. PubMed ID: 27282910
[TBL] [Abstract][Full Text] [Related]
18. Glioblastoma: exosome and microRNA as novel diagnosis biomarkers.
Saadatpour L; Fadaee E; Fadaei S; Nassiri Mansour R; Mohammadi M; Mousavi SM; Goodarzi M; Verdi J; Mirzaei H
Cancer Gene Ther; 2016 Dec; 23(12):415-418. PubMed ID: 27834360
[TBL] [Abstract][Full Text] [Related]
19. Gene and microRNA Signatures Are Associated with the Development and Survival of Glioblastoma Patients.
Yang Q; Wang R; Wei B; Peng C; Wang L; Hu G; Kong D; Du C
DNA Cell Biol; 2019 Jul; 38(7):688-699. PubMed ID: 31188028
[TBL] [Abstract][Full Text] [Related]
20. Aberrant miRNAs Regulate the Biological Hallmarks of Glioblastoma.
Yu W; Liang S; Zhang C
Neuromolecular Med; 2018 Dec; 20(4):452-474. PubMed ID: 30182330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
